バーサーノン 化学特性,用途語,生産方法
効能
抗炎症薬, ケモカイン受容体9拮抗薬
説明
Vercirnon is an orally bioavailable antagonist of chemokine receptor 9 (CCR9) with an IC
50 value of 5.4 nM for inhibition of CCL25-induced calcium mobilization in Molt-4 cells. It is selective for CCR9 over CCR1-12 and CX3CR1-7 (IC
50s = >10 μM for all). It also inhibits CCL25-induced Molt-4 chemotaxis in 0.1% BSA/HBSS and in 100% human AB serum (IC
50s = 3.5 and 33.4 nM, respectively), as well as chemotaxis of human T cells stimulated by retinoic acid (RA) and mouse and rat thymocytes. Vercirnon binds allosterically to the intracellular side of CCR9 and prevents G protein coupling.
バーサーノン 上流と下流の製品情報
原材料
準備製品